Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, Jihoon | - |
dc.contributor.author | Hyung, Sujin | - |
dc.contributor.author | Heo, You Jeong | - |
dc.contributor.author | Jung, Sangmin | - |
dc.contributor.author | Kim, Seung Tae | - |
dc.contributor.author | Park, Se Hoon | - |
dc.contributor.author | Hong, Jung Yong | - |
dc.contributor.author | Lim, Sung Hee | - |
dc.contributor.author | Kim, Kyoung-Mee | - |
dc.contributor.author | Yoo, Sanghee | - |
dc.contributor.author | Li Jeon, Noo | - |
dc.contributor.author | Lee, Jeeyun | - |
dc.date.accessioned | 2024-05-11T14:30:19Z | - |
dc.date.available | 2024-05-11T14:30:19Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.issn | 1878-5905 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91162 | - |
dc.description.abstract | This study addresses the demand for research models that can support patient-treatment decisions and clarify the complexities of a tumor microenvironment by developing an advanced non-animal preclinical cancer model. Based on patient-derived tumor spheroids (PDTS), the proposed model reconstructs the tumor microenvironment with emphasis on tumor spheroid-driven angiogenesis. The resulting microfluidic chip system mirrors angiogenic responses elicited by PDTS, recapitulating patient-specific tumor conditions and providing robust, easily quantifiable outcomes. Vascularized PDTS exhibited marked angiogenesis and tumor proliferation on the microfluidic chip. Furthermore, a drug that targets the vascular endothelial growth factor receptor 2 (VEGFR2, ramucirumab) was deployed, which effectively inhibited angiogenesis and impeded tumor invasion. This innovative preclinical model was used for investigating distinct responses for various drug combinations, encompassing HER2 inhibitors and angiogenesis inhibitors, within the context of PDTS. This integrated platform could potentially advance precision medicine by harmonizing diverse data points within the tumor microenvironment with a focus on the interplay between cancer and the vascular system. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.title | Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer | - |
dc.type | Article | - |
dc.identifier.wosid | 001197778600001 | - |
dc.identifier.doi | 10.1016/j.biomaterials.2024.122504 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.306 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85185403342 | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 306 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Angiogenesis | - |
dc.subject.keywordAuthor | Microfluidic chip | - |
dc.subject.keywordAuthor | Patient -derived tumor spheroids | - |
dc.subject.keywordAuthor | And vascular endothelial growth factor | - |
dc.subject.keywordAuthor | receptor 2 (VEGFR2) | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.